Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer

Gastroenterology

Volumn 154, Issue 4, 2018, Pages 906-915.e7

  Sineshaw, Helmneh M ^a   Ng, Kimmie ^b   Flanders, W Dana ^a,c   Brawley, Otis W ^a   Jemal, Ahmedin ^a  

^a AMERICAN CANCER SOCIETY   (Georgia)

^b HARVARD MEDICAL SCHOOL   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Colon Cancer; Comorbidity; Mortality; Race

Indexed keywords

ADULT; ALGORITHM; ARTICLE; BLACK PERSON; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CAUCASIAN; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE DIFFERENCE; RECTUM CANCER; TREATMENT OUTCOME; ADOLESCENT; AFRICAN AMERICAN; CANCER STAGING; COLORECTAL TUMOR; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; FACTUAL DATABASE; HEALTH CARE DISPARITY; HEALTH DISPARITY; INSURANCE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 85043256773     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2017.11.005     Document Type: Article

References (50)

1. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2017. CA Cancer J Clin 67 (2017), 7–30.
2. Kohler, B.A., Sherman, R.L., Howlader, N., et al. Annual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst, 107, 2015, djv048.
3. Siegel, R.L., Fedewa, S.A., Anderson, W.F., et al. Colorectal cancer incidence patterns in the United States, 1974–2013. J Natl Cancer Inst, 109, 2017, djw322.
4. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2016. CA Cancer J Clin 66 (2016), 7–30.
5. Rahman, R., Schmaltz, C., Jackson, C.S., et al. Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States. Cancer Med 4 (2015), 1863–1870.
6. Jessup, J.M., Stewart, A., Greene, F.L., et al. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 294 (2005), 2703–2711.
7. Potosky, A.L., Harlan, L.C., Kaplan, R.S., et al. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20 (2002), 1192–1202.
8. Holowatyj, A.N., Ruterbusch, J.J., Rozek, L.S., et al. Racial/ethnic disparities in survival among patients with young-onset colorectal cancer. J Clin Oncol 34 (2016), 2148–2156.
9. Wallace, K., Hill, E.G., Lewin, D.N., et al. Racial disparities in advanced-stage colorectal cancer survival. Cancer Causes Control 24 (2013), 463–471.
10. Wallace, K., Sterba, K.R., Gore, E., et al. Prognostic factors in relation to racial disparity in advanced colorectal cancer survival. Clin Colorectal Cancer 12 (2013), 287–293.
11. Phatak, U.R., Kao, L.S., Millas, S.G., et al. Interaction between age and race alters predicted survival in colorectal cancer. Ann Surg Oncol 20 (2013), 3363–3369.
12. Lai, Y., Wang, C., Civan, J.M., et al. Effects of cancer stage and treatment differences on racial disparities in survival from colon cancer: a United States population-based study. Gastroenterology 150 (2016), 1135–1146.
13. Soneji, S., Iyer, S.S., Armstrong, K., et al. Racial disparities in stage-specific colorectal cancer mortality: 1960-2005. Am J Public Health 100 (2010), 1912–1916.
14. Mayberry, R.M., Coates, R.J., Hill, H.A., et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst 87 (1995), 1686–1693.
15. Silber, J.H., Rosenbaum, P.R., Ross, R.N., et al. Racial disparities in colon cancer survival: a matched cohort study. Ann Intern Med 161 (2014), 845–854.
16. Marcella, S., Miller, J.E., Racial differences in colorectal cancer mortality: the importance of stage and socioeconomic status. J Clin Epidemiol 54 (2001), 359–366.
17. Wray, C.M., Ziogas, A., Hinojosa, M.W., et al. Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis. Dis Colon Rectum 52 (2009), 1359–1366.
18. Le, H., Ziogas, A., Lipkin, S.M., et al. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev 17 (2008), 1950–1962.
19. Breslin, T.M., Morris, A.M., Gu, N., et al. Hospital factors and racial disparities in mortality after surgery for breast and colon cancer. J Clin Oncol 27 (2009), 3945–3950.
20. Tehranifar, P., Neugut, A.I., Phelan, J.C., et al. Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomarkers Prev 18 (2009), 2701–2708.
21. Du, X.L., Fang, S., Vernon, S.W., et al. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer 110 (2007), 660–669.
22. Haas, J.S., Brawarsky, P., Iyer, A., et al. Association of area sociodemographic characteristics and capacity for treatment with disparities in colorectal cancer care and mortality. Cancer 117 (2011), 4267–4276.
23. Simpson, D.R., Martínez, M.E., Gupta, S., et al. Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer. J Natl Cancer Inst 105 (2013), 1814–1820.
24. American College of Surgeons. National Cancer Data Base: 2017 update. Available at: https://www.facs.org/quality-programs/cancer/ncdb. Accessed January 26, 2017.
25. Commission on Cancer. FORDS: Facility Oncology Registry Data Standards—Revised for 2012. Available at: https://www.facs.org/∼/media/files/quality%20programs/cancer/coc/fords/fords%202012c.ashx. Accessed November 16, 2016.
26. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-sixth Annual SAS Users group international conference. SAS Institute, Cary, NC. 2001;26:214–226.
27. Rosenbaum, P.R., Rubin, D.B., Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79 (1984), 516–524.
28. Charlson, M.E., Pompei, P., Ales, K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987), 373–383.
29. Halpern, M.T., Ward, E.M., Pavluck, A.L., et al. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol 9 (2008), 222–231.
30. Ward, E., Halpern, M., Schrag, N., et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 58 (2008), 9–31.
31. Sabatino, S.A., White, M.C., Thompson, T.D., et al. Cancer screening test use—United States, 2013. MMWR Morb Mortal Wkly Rep 64 (2015), 464–468.
32. Ayanian, J.Z., Weissman, J.S., Schneider, E.C., et al. Unmet health needs of uninsured adults in the United States. JAMA 284 (2000), 2061–2069.
33. McMorrow, S., Long, S.K., Kenney, G.M., et al. Uninsurance disparities have narrowed for black and Hispanic adults under the Affordable Care Act. Health Aff (Millwood) 34 (2015), 1774–1778.
34. Doubeni, C.A., Field, T.S., Buist, D.S., et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer 109 (2007), 612–620.
35. Thornton, J.G., Morris, A.M., Thornton, J.D., et al. Racial variation in colorectal polyp and tumor location. J Natl Med Assoc, 99, 2007, 723.
36. Agrawal, S., Bhupinderjit, A., Bhutani, M.S., et al. Colorectal cancer in African Americans. Am J Gastroenterol 100 (2005), 515–523.
37. Baldwin, L.-M., Dobie, S.A., Billingsley, K., et al. Explaining black–white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst 97 (2005), 1211–1220.
38. Ayanian, J.Z., Zaslavsky, A.M., Fuchs, C.S., et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 21 (2003), 1293–1300.
39. Demissie, K., Oluwole, O.O., Balasubramanian, B.A., et al. Racial differences in the treatment of colorectal cancer: a comparison of surgical and radiation therapy between whites and blacks. Ann Epidemiol 14 (2004), 215–221.
40. Hayanga, A.J., Waljee, A.K., Kaiser, H.E., et al. Racial clustering and access to colorectal surgeons, gastroenterologists, and radiation oncologists by African Americans and Asian Americans in the United States: a county-level data analysis. Arch Surg 144 (2009), 532–535.
41. Huang, L.C., Tran, T.B., Ma, Y., et al. What factors influence minority use of high volume hospitals for colorectal cancer care. Dis Colon Rectum, 58, 2015, 526.
42. Phipps, A.I., Limburg, P.J., Baron, J.A., et al. Association between molecular subtypes of colorectal cancer and patient survival. Gastroenterology 148 (2015), 77–87.e2.
43. Carethers, J.M., Murali, B., Yang, B., et al. Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer. PLoS One, 9, 2014, e100461.
44. Ball, J.K., Elixhauser, A., Treatment differences between blacks and whites with colorectal cancer. Med Care 34 (1996), 970–984.
45. Sanoff, H.K., Sargent, D.J., Green, E.M., et al. Racial differences in advanced colorectal cancer outcomes and pharmacogenetics: a subgroup analysis of a large randomized clinical trial. J Clin Oncol 27 (2009), 4109–4115.
46. Yoon, H.H., Shi, Q., Alberts, S.R., et al. Racial differences in BRAF/KRAS mutation rates and survival in stage III colon cancer patients. J Natl Cancer Inst, 107, 2015, djv186.
47. Mettlin, C.J., Menck, H.R., Winchester, D.P., et al. A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program. Cancer 79 (1997), 2052–2061.
48. Ries L, Melbert D, Krapcho M, et al. SEER cancer statistics review, 1975–2014. Available at: https://seer.cancer.gov/csr/1975_2014/. Bethesda, MD; National Cancer Institute.
49. Surveillance Epidemiology, and End Results (SEER) Program Research Data (1973-2014), National Cancer Institute, DCCPS, Surveillance Research Program, released April 2017, based on the November 2016 submission. Available at: www.seer.cancer.gov. Accessed August 2, 2017.
50. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-sixth Annual SAS Users group international conference. SAS Institute, Cary, NC. 2001;26:214–226.